Among the key strengths of the company, analysts highlight, are long-term relationships with leading industry customers, strong focus on R&D, established infrastructure with backward integration along with strong and consistent financial performance.
Harsha Engineers International, Electronics Mart India, DCX Systems, Dreamfolks Services and Campus Activewear were among mainboard issues that saw over 50 times subscription in FY23.
Mankind Pharma IPO: The company is almost entirely focussed in India. The domestic market contributed 97.60 percent to the company s revenue from operations in FY22
Avalon IPO shares now traded flat to negative in the grey market, analysts on anonymity said. The sharp profit booking in the equity markets after nine-day run might also impact the listing performance.